We are committed to changing the existing Pharmaceutical status quo . Today, the first world enjoys benefits from the latest innovations in healthcare and pharmaceutical development while poor countries receive little or none of these benefits. Even access to medicines such as insulin which is commonly available (and expensive) in the United States, is severely limited in many poorer countries.
Our strategy is to identify opportunities in the US and worldwide to work with organizations and governments to develop mechanisms that will deliver medicines to people in need and to eliminate cost barriers that restrict patient access. We have identified opportunities where we believe that we can help in a significant way. Because the price of insulin in the United States has increased by 500% over the last decade, we have identified it as our first target for manufacture.
We reach out to the broad community in our home country, and in the broader world to develop effective and meaningful partnerships in order to deliver on our goal: a more egalitarian world in which patients receive needed medications at an affordable price.